SCHEMBL9681447

SCHEMBL9681447

OCc1ccc2c(c1)Sc1ccccc1CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 3/20 0.35
KDM4E B2RXH2 2/20 0.35
NAMPT P43490 2/20 0.35
TSHR P16473 1/20 0.34
DRD2 P14416 3/20 0.34
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
TTR P02766 1/20 0.33
PDK2 Q15119 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28487486 0.90 ALDH1A1 (0.42) GRIN2BALDH1A1LMNAHPGDKDM4E
SCHEMBL11103482 0.88 GRIN2B (0.34) GRIN2BNAMPTCHRNB4CHRNA3CHRNA7
SCHEMBL9681458 0.81 NAMPT (0.36) NAMPT
SCHEMBL4488551 0.77 ALDH1A1 (0.50) ALDH1A1LMNAHPGDKDM4ETSHR
SCHEMBL11100489 0.76 MAPT (0.43) ALDH1A1LMNAHPGDNAMPTTSHR
SCHEMBL11010781 0.75 KMT2A (0.63) ALDH1A1LMNAHPGDKDM4EMEN1
SCHEMBL10503021 0.74 DRD2 (0.35) LMNADRD2
SCHEMBL11098487 0.74 ALDH1A1 (0.41) ALDH1A1HPGDNAMPTTSHRHTT
SCHEMBL7241941 0.73 GRIN2B (0.33) GRIN2BLMNAHPGDNAMPTCHRNB4
SCHEMBL7111900 0.73 ALDH1A1 (0.41) ALDH1A1LMNAHPGDKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463636-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1992-01-02 EP claimed
EP-0166257-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1986-01-02 EP claimed
EP-0029587-A1 3-Hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions MERCK SHARP & DOHME (I.A.) CORP. (US) 1981-06-03 EP claimed
US-4237160-A 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists MERCK SHARP & DOHME (I.A.) CORP. (US) 1980-12-02 US claimed
EP-0463636-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1992-01-02 EP disclosed
US-4558037-A A DIBENZOTHIEPIN COMPOUND AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR MERCK & CO., INC. (US) 1985-12-10 US disclosed
US-4535171-A Dibenzo[b,f]thiepin-3-carboxaldehydes as prostaglandin antagonists MERCK FROSST CANADA, INC. (CA) 1985-08-13 US disclosed
EP-0138532-A2 3-Substituted dibenzo [b,f] thiepins, compositions containing them and their use as prostaglandin antagonists MERCK FROSST CANADA INC. (CA) 1985-04-24 EP disclosed
EP-0029587-B1 3-HYDROXYMETHYLDIBENZO(B,F)THIEPINS AND DIBENZO(B,F)THIEPIN-3-CARBOXALDEHYDES AS PROSTAGLANDIN ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS MERCK SHARP & DOHME (I.A.) CORP. (US) 1984-06-13 EP disclosed
EP-0029587-A1 3-Hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions MERCK SHARP & DOHME (I.A.) CORP. (US) 1981-06-03 EP disclosed
US-4237160-A 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists MERCK SHARP & DOHME (I.A.) CORP. (US) 1980-12-02 US disclosed